Medicinal Products Regulation (EEA AMV).

The regulation applies rules to the trade, approval, labeling, and monitoring of both human and veterinary medicinal products within Liechtenstein, harmonizing national law with EU directives. For animal health, it specifically implements Directive 2001/82/EC on veterinary medicinal products, establishing detailed procedures for the parallel import and distribution of veterinary drugs. The ordinance sets requirements for authorization, packaging, labeling, pharmacovigilance, and reporting of adverse events or misuse. It mandates that veterinary medicines can only be approved for trade if withdrawal periods are sufficient to protect consumers from drug residues in animal-derived food. The regulation also requires comprehensive record-keeping and reporting obligations for wholesalers and veterinarians, ensuring transparency and safety in the use and trade of veterinary drugs for animal health in Liechtenstein. The text consists of 21 Articles.